Back to Agenda
Session 2 Track E: The New Face of Health Care
Session Chair(s)
Vickee Beissel Altman, MEd, RN
MSA National MSL Manager
Roche Diagnostics, United States
The basics of health care have not changed: right diagnosis, right treatment, right time. This reflects an early concept of “personalized care” recognizing that “one size does NOT fit all” when managing patient care. Today the face of health care continues to evolve including increasing expectations that patients will have access to the “right” diagnostic and treatment strategies at the most efficient cost, all while finding a way to improve overall health economics. The goal is to assure that every eligible patient is identified and is tested by the appropriate diagnostic test leading to selection and administration of the correct pharmaceutical or other intervention at a per capita cost that is sustainable.
The question, “How does this evolving new face of health care impact the MSL?”
The speakers will explore the following specific areas related to this question:
· Multispecialty Care & Delivery increases key stakeholders
· Expanding Definition from individual to organizations and from clinicians to administrators
· Informatics Driving Integration Across Modalities
· Molecular Imaging Biomarkers for clinical trials and patient management
· Power, “Where Does It Sit?”
· Risk, “How Is It Shifting?”
· Impact on KOL Access and Engagement Strategies
Speaker(s)
Faculty
Kevin Appareti
Royal Philips, United States
Senior Director, Global Medical Science Liaison
Faculty
Lisaann Trembath
Avid Radiopharmaceuticals, Inc., United States
Associate Director of Clinical Imaging Operations
Have an account?